Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jacc.2018.07.058 | DOI Listing |
Heart Rhythm
August 2024
AIG Institute of Cardiac Sciences, Hyderabad, India. Electronic address:
Background: A lack of standard Bachmann bundle (BB) capture criteria has affected the clinical impact of Bachmann bundle area pacing (BBAP) in patients with interatrial block (IAB).
Objective: The purpose of this study was to evaluate the feasibility and safety of electrogram-guided Bachmann bundle pacing (BBP) using sheath assisted, stylet-driven atrial lead implantation.
Methods: Patients with baseline IAB undergoing dual-chamber pacemaker or implantable cardioverter-defibrillator implantation were enrolled in a single-center prospective study.
Cardiol Rev
February 2024
Department of Internal Medicine, Hennepin Healthcare, Minneapolis, MN.
Heart failure with preserved ejection fraction (HFpEF) is a prevalent and challenging condition with limited therapeutic options. This meta-analysis aims to assess the feasibility and effectiveness of interatrial shunt devices (IASD) in the treatment of HFpEF, focusing on key hemodynamic parameters and clinical outcomes. Six clinical trials, encompassing 324 patients, were included in this analysis.
View Article and Find Full Text PDFJ Cardiothorac Surg
October 2023
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Objective: To evaluate the fiber-degradation and endothelialization of a modified poly L-lactic acid (PLLA) atrial septal defect (ASD) occluder for a long time in vivo.
Methods: A total of 57 New Zealand rabbits were selected to establish the vasculature implantation model, which would be used to characterize the mechanical properties and pathological reaction of PLLA filaments (a raw polymer of ASD occluder). In total, 27 Experimental piglets were used to create the ASD model for the catheter implantation of PLLA ASD occluders.
Egypt Heart J
August 2023
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, DKI Jakarta, 11420, Indonesia.
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious disease that can progress and lead to a deadly outcome. Despite optimal drug therapy, pulmonary hypertension (PH) remains fatal. Untreatable right heart failure (RHF) from CTEPH is eventually a significant cause of death.
View Article and Find Full Text PDFCardiol Res
August 2023
Department of Cardiology, Arrowhead Regional Medical Center, Colton, CA 92324, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!